Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Latest news on SUCAMPO PHARMACEUTICALS, I
10/03 SUCAMPO PHARMACEUTICALS : Announces FDA Acceptance of sNDA for AMITIZA in Childr..
10/02 SUCAMPO PHARMACEUTICALS : Announces Presentation at Deutsche Bank's 25th Annual ..
09/28 Sucampo Pharmaceuticals Announces FDA Acceptance of sNDA for AMITIZA in Child..
09/28 Sucampo Pharmaceuticals Announces Presentation at Deutsche Bank’s 25th ..
09/26 SUCAMPO PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements a..
09/26 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at the 2017
09/22 SUCAMPO PHARMACEUTICALS ANNOUNCES WE : Rare Disease & Immuno-Oncology
09/21 CANCER PREVENTION PHARMACEUTICALS : Receives $9.5 Million in Additional Funding ..
09/21 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at the 2017 Cant..
09/21 SUCAMPO PHARMACEUTICALS ANNOUNCES WE : Rare Disease & Immuno-Oncology
09/20 SUCAMPO PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Finan..
09/20 Sucampo Pharmaceuticals Appoints Alex Driggs as General Counsel
09/19 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at the 2017 Cant..
09/14 SUCAMPO PHARMACEUTICALS : Cancer Prevention Pharmaceuticals Receives $9.5 Millio..
09/11 SUCAMPO PHARMACEUTICALS : Cancer Prevention Pharmaceuticals Receives $9.5 Millio..
09/11 SUCAMPO PHARMACEUTICALS, INC. (NASDA : SCMP) Files An 8-K Entry into a Material ..
09/08 SUCAMPO PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement (form..
08/30 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Wel..
08/11 SUCAMPO PHARMACEUTICALS : Study Results Published in The Lancet Demonstrate Safe..
08/07 SUCAMPO PHARMACEUTICALS : Drug Makers Stock Performance Review -- DURECT, Sucamp..
08/02 SUCAMPO PHARMACEUTICALS : reports 2Q loss
08/02 SUCAMPO PHARMACEUTICALS : Management's Discussion and Analysis of Financial Cond..
08/02 SUCAMPO PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, R..
08/02 SUCAMPO PHARMACEUTICALS, INC. (NASDA : SCMP) Files An 8-K Results of Operations ..
08/02 Sucampo Reports Second Quarter 2017 Financial Results
08/02 SUCAMPO PHARMACEUTICALS, INC. : Investor Network: Sucampo Pharmaceuticals, Inc. ..
07/19 SUCAMPO PHARMACEUTICALS, INC. (NASDA : SCMP) Files An 8-K Departure of Directors..
07/19 SUCAMPO PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Regul..
07/19 Sucampo Announces Second Quarter 2017 Earnings Call
07/18 Dr. Karen Smith Joins Sucampo’s Board of Directors
06/13 Sucampo Pharmaceuticals Announces Issuance of New Patent for VTS-270
06/06 SUCAMPO PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Chan..
06/01 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Jefferie..
05/22 SUCAMPO PHARMACEUTICALS : Financial Statements and Exhibits (form 8-K/A)
05/22 SUCAMPO PHARMACEUTICALS : Technical Reports on Drug Makers Stocks -- Synergy Pha..
05/15 SUCAMPO PHARMACEUTICALS : Cerecor Appoints Steven Boyd and Peter Greenleaf to Bo..
05/12 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at the Bank of A..
05/11 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Bank of ..
05/03 SUCAMPO PHARMACEUTICALS : Management's Discussion and Analysis of Financial Cond..
05/03 SUCAMPO PHARMACEUTICALS, INC. : Investor Network: Sucampo Pharmaceuticals, Inc. ..
05/03 SUCAMPO PHARMACEUTICALS : tops 1Q revenue forecasts
05/03 SUCAMPO PHARMACEUTICALS, INC. (NASDA : SCMP) Files An 8-K Results of Operations ..
05/03 SUCAMPO PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, R..
05/03 Sucampo Reports First Quarter 2017 Financial Results
04/27 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at the Deutsche ..
04/26 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Deutsche..
04/19 SUCAMPO PHARMACEUTICALS : New Study Published in PLOS ONE Advances Science Aroun..
04/19 Sucampo Announces First Quarter 2017 Earnings Call
04/18 SUCAMPO PHARMACEUTICALS : New Study Published in PLOS ONE Advances Science Aroun..
04/18 SUCAMPO PHARMACEUTICALS : New Study Published in PLOS ONE Advances Science Aroun..
04/05 SUCAMPO PHARMACEUTICALS : Drug Makers Stocks Under Scanner -- Synergy Pharma, No..
04/03 SUCAMPO PHARMACEUTICALS, INC. (NASDA : SCMP) Files An 8-K Entry into a Material ..
04/03 SUCAMPO PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Comp..
04/03 DGAP-NEWS : Sucampo Acquires Vtesse Inc.
04/03 Sucampo Acquires Vtesse Inc.
04/03 SUCAMPO PHARMACEUTICALS : Acquires Vtesse Inc.
03/29 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at the 16th Annu..
03/28 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 16th Ann..
03/15 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Oppenhei..
03/13 SUCAMPO PHARMACEUTICALS, INC. (NASDA : SCMP) Files An 8-K Regulation FD Disclosu..
03/13 SUCAMPO PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements a..
03/08 SUCAMPO PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
03/08 SUCAMPO PHARMACEUTICALS : SCMP) Jumps on Q4 Results
03/08 SUCAMPO PHARMACEUTICALS : tops 4Q revenue forecasts
03/08 SUCAMPO PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, C..
03/08 Sucampo Reports Fourth Quarter and Full Year 2016 Financial Results
02/23 Sucampo Announces Fourth Quarter and Full Year 2016 Earnings Call
02/09 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Lee..
01/09 SUCAMPO PHARMACEUTICALS, INC. (NASDA : SCMP) Files An 8-K Regulation FD Disclosu..
01/09 SUCAMPO PHARMACEUTICALS : Announces Pricing of $260.0 Million 3.25% Convertible ..
01/09 SUCAMPO PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements a..
2016 SUCAMPO PHARMACEUTICALS, INC. (NASDA : SCMP) Files An 8-K Entry into a Material ..
2016 SUCAMPO PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Crea..
2016 SUCAMPO PHARMACEUTICALS : Announces Pricing of $260.0 Million 3.25% Convertible ..
2016 SUCAMPO PHARMACEUTICALS, INC. (NASDA : SCMP) Announces Its New Debt Offering Of ..
1  2  3  4Next
Financials ($)
Sales 2017 234 M
EBIT 2017 37,6 M
Net income 2017 -40,0 M
Debt 2017 243 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018 13,49
EV / Sales 2017 3,07x
EV / Sales 2018 2,50x
Capitalization 477 M
Chart SUCAMPO PHARMACEUTICALS, I
Duration : Period :
Sucampo Pharmaceuticals, I Technical Analysis Chart | SCMP | US8649091068 | 4-Traders
Technical analysis trends SUCAMPO PHARMACEUTICALS, I
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 17,3 $
Spread / Average Target 69%
EPS Revisions
Managers
NameTitle
Peter S. Greenleaf Chairman & Chief Executive Officer
Peter P. Pfreundschuh Chief Financial Officer
Peter Lichtlen Chief Medical Officer
Peter Alec Kiener Chief Scientific Officer
Maureen E. O'Connell Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SUCAMPO PHARMACEUTICALS, INC.-24.72%475
GILEAD SCIENCES11.73%104 487
REGENERON PHARMACEUTICALS19.69%47 079
VERTEX PHARMACEUTICALS110.07%39 018
ACTELION23.81%29 869
GENMAB14.75%12 912